Recombinant SARS-CoV-2, NTD Protein

Cat# S853-1

Size : 1mg

Brand : Leinco Technologies

Request more information

Contact local distributor :


Phone : +1 850 650 7790

Recombinant SARSCoV2, NTD Protein

Product No.: S853

Alternate Names
Spike protein, S Protein, NTD, Nterminal RNAbinding domain
Product Type
Recombinant Protein
Expression Host
HEK293 Cells
Species
SARSCoV2
Virus
Applications
ELISA

Data

NTD Protein (S853) dataPurified SARSCoV2 NTerminal Domain (NTD) Spike Protein under nonreducing conditions (Prod. No. S853)

Background

Severe acute respiratory syndrome coronavirus 2 (SARSCoV2), the causative agent of coronavirus disease 2019 (COVID19), is an enveloped, singlestranded, positivesense RNA virus that belongs to the Coronaviridae family 1. The SARSCoV2 genome, which shares 79.6% identity with SARSCoV, encodes four essential structural proteins: the spike (S), envelope (E), membrane (M), and nucleocapsid protein (N) 2. The S protein is a transmembrane, homotrimeric, class I fusion glycoprotein that mediates viral attachment, fusion, and entry into host cells 3. Each ~180 kDa monomer contains two functional subunits, S1 (~700 a.a) and S2 (~600 a.a), that mediate viral attachment and membrane fusion, respectively. S1 contains two major domains, the Nterminal (NTD) and Cterminal domains (CTD). In both SARSCoV and SARSCoV2, the CTD contains the receptorbinding domain (RBD), which binds to the angiotensinconverting enzyme 2 (ACE2) receptor on host cells35. The NTD of SARSCoV2 does not bind to ACE26, and the function of NTD in SARSCoV2 infection is not well understood. In other CoVs, the NTD may promote attachment by binding to sugar moieties7 and might play a role in the conformational change of S2 required for membrane fusion8. While most neutralizing antibodies target the RBD domain and block receptor binding, potent neutralizing antibodies targeting NTD were isolated from convalescent COVID19 patients9, identifying the NTD as an attractive candidate for vaccines and therapeutics. In addition, the NTD is a promising antigen for diagnostic tests, as there is only 53.5% homology between the NTD of SARSCoV2 and SARSCoV10.

Protein Details

Format
Purified No Carrier Protein
Purity
>95% by SDS Page
Product Concentration
0.5 mg/ml
Endotoxin Level
<0.10 EU per 1 μg of the protein by the LAL method
Protein Accession No.
Amino Acid Sequence
VNLTTRTQLPPAYTNSFTRGVYYPDKVFRSSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKRFDNPVLPFNDGVYFASTEKSNIIRGWIFGTTLDSKTQSLLIVNNATNVVIKVCEFQFCNDPFLGVYYHKNNKSWMESEFRVYSSANNCTFEYVSQPFLMDLEGKQGNFKNLREFVFKNIDGYFKIYSKHTPINLVRDLPQGFSALEPLVDLPIGINITRFQTLLALHRSYLTPGDSSSGWTAGAAAYYVGYLQPRTFLLKYNENGTITDAVDCALDPLSETKCTLKS
State of Matter
Sterile Liquid
Predicted Molecular Mass
The predicted molecular mass is ~36 kDa.
Predicted Molecular Mass
~36 kDa
Formulation
This recombinant protein is aseptically packaged and formulated in 0.01 M phosphate buffered saline (PBS) pH 7.2 7.4, 150 mM NaCl with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of proteins, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration.
Storage and Stability
This recombinant protein may be stored as received at 28°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at 80°C. Avoid Repeated Freeze Thaw Cycles.
Country of Origin
USA
Shipping
Next Day
NCBI Gene Bank
Applications and Recommended Usage ?
(Quality Tested by Leinco)
ELISA

References & Citations

1. Zhou, P., Yang, X., Wang, X. et al. Nature 579, 270–273. 2020.
2. Wu, F., Zhao, S., Yu, B. et al. Nature 579, 265–269. 2020.
3. Wrapp D, Wang N, Corbett KS, et al. bioRxiv. 2020.
4. Walls AC, Park YJ, Tortorici MA, et al. Cell. 181(2):281292.e6. 2020.
5. Li W, Zhang C, Sui J, et al. EMBO J. 24(8):16341643. 2020.
6. Wang Q, Zhang Y, Wu L, et al. Cell. 181(4):894904.e9. 2020.
7. Park, Y., Walls, A.C., Wang, Z. et al. Nat Struct Mol Biol 26, 1151–1157. 2019.
8. Zhou, H., Chen, Y., Zhang, S. et al. Nat Commun 10, 3068. 2019.
9. Chi X, Yan R, Zhang J, et al. Science. eabc6952. 2020.
10. Ou, X., Liu, Y., Lei, X. et al. Nat Commun 11, 1620. 2020.